Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 6 of 15
Re-treatment 225Ac-J591 for mCRPC
NCT04576871
Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2
NCT04179305
Social Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life Depression
NCT04487730
Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
NCT04406389
Radiofrequency Ablation of Atrial Fibrillation Under Apnea
NCT04170894
Patient-caregiver Communication Intervention for Prognostic Understanding
NCT03833817
Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety
NCT04050800
Reaching and Engaging Depressed Senior Center Clients
NCT04289298
Trauma-focused Psychodynamic Psychotherapy for LGBT Patients With Post-traumatic Stress Disorder
NCT04532996
Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region
NCT04298554
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
NCT03679624
Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery
NCT04230980
Trial to Test Effectiveness of Depression Intervention for Mistreated Older Adults
NCT04258579
Use of Cast Iron Pots to Improve Maternal Anemia
NCT02341300
Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis
NCT04273867
Fetal Genome Profiling Via Trophoblast Cells
NCT03832634
Narrative Medicine and Pediatric Oncology
NCT04489316
A Media Communication Intervention to Increase Engagement in Advance Care Planning Among Cancer Patients
NCT04208009
Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis
NCT03991936
Expansion of Abbreviations and Acronyms for Patients
NCT05297942
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
NCT03998488
Lavender Aromatherapy Spine Procedure Study
NCT04156009
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer
NCT04220983
Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1
NCT04158908
Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy
NCT04171635
A Pilot Study of a Strategy and Computer-based Intervention to Enhance Daily Cognitive Functioning After Stroke
NCT04098835
Trifocal Intraocular Lens (IOL) Aberrometry Outcomes
NCT04196569
Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies
NCT04030572
Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients
NCT04103645
Low Doses of Aspirin in the Prevention of Preeclampsia
NCT04070573
Web-based Family History Tool
NCT04890327
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
NCT03878927
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
NCT03921242
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
NCT03930771
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
NCT03921021
Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD
NCT04159584
Reward Function and Therapy for Late-Life Depression
NCT03688139
Developing a Pain Identification and Communication Toolkit
NCT03853291
Study of the Food Order Behavioral Intervention in Prediabetes
NCT03896360
Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine
NCT03802864
A Personalized Health Behavior System
NCT03538158
Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)
NCT03634800
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)
NCT03583099
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
NCT03581227
Effects of Perampanel on Neurophysiology Test Perimeters
NCT03653741
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
NCT03585725
HCV Seek, Test and Rapid Treatment for Young PWID
NCT03627546
Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
NCT03223298
MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer
NCT03664193
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls
NCT03675282
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.